| Term 
 | Definition 
 
        | Chantix; partial nicotinic agonist use: smoking cessation
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | depolarizing NMJ blocker; nicotinic agonsist effect:: paralysis
 use: surgery
 contraindications: pseudocholinesterase deficiency (permanent paralysis) & malignant hyperthermia (muscle shivering causes dangerous rise in body T)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | nicotinic antagonist effect: paralysis for surgery
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | nicotinic antagonist effect: paralysis for surgery
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | nicotinic antagonist effect: paralysis for surgery
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | nicotinic antagonist effect: paralysis for surgery
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | nicotinic antagonist effect: paralysis for surgery; very selective for NMJ receptor |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | nicotinic antagonist effect: paralysis for surgery; releases histamine
 very selective for NMJ receptor
 short acting
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | nicotinic antagonist effect: paralysis for surgery
 less selective for NMJ receptor
 long acting
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | beta-1 agonist effect: positive inotropy > positive chronotropy
 use: acute CHF
 tachyphylaxis occurs; use for first few days
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | beta-1 antagonist (partial agonist)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | beta-1 antagonist Tenormin
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | beta-1 antagonist Lopressor, Toprol XL
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | beta-1 antagonist Brevibloc
 IV, short acting
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | beta-2 agonist IV
 use: tocolytic
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | nonselective beta agonist |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | phoshphodiesterase-4 inhibitor Daliresp
 use: COPD, asthma
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | nonselective beta antagonist |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | nonselective beta antagonist |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | nonselective beta antagonist |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | nonselective beta antagonist |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | nonselective beta antagonist |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | nonselective beta antagonist |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | alpha-1 agonist eyedrop, tablet, IV, nasal spray
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | alpha-1 antagonist Cardura
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | alpha-1 antagonist Uroxatral
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | alpha-1 antagonist Rapaflo
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | alpha-1A selective antagonist Flomax
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | alpha-1, beta-1, beta-2 antagonist |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | alpha-1, beta-1, beta-2 antagonist Coreg
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | nonselective alpha antagonist |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | nonselective alpha antagonist |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | nonDHP CCB more negative inotropy than diltiazem
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | DHP CCB no first pass effect :)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | HMG CoA Reductase Inhibitor |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | HMG CoA Reductase Inhibitor |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | HMG CoA Reductase Inhibitor |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | HMG CoA Reductase Inhibitor |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | HMG CoA Reductase Inhibitor |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | HMG CoA Reductase Inhibitor |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | HMG CoA Reductase Inhibitor |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | effect: inhibit cAMP -> inhibit TG synthesis & lipolysis |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | cholesterol absorption inhibitor in smint |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | HDL cannot transfer to VLDL/LDL -> increase HDL (future drug)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | LDL receptor cannot degrade -> more LDL receptors on surface -> decrease LDL |  | 
        |  |